Top compounds associated with response to CXXC5


Feature Type Standardized
Nominal ANOVA
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.089 0.006
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.006
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.081 0.006
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.095 0.006
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.007
mRNA BHG712 GDSC1000 pan-cancer AAC 0.081 0.007
mRNA AZ628 GDSC1000 pan-cancer AAC 0.13 0.007
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.007
mRNA LE-135 CTRPv2 pan-cancer AAC -0.1 0.008
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.008
Download CSV